Literature DB >> 8912737

Respiratory muscle and cardiopulmonary function during exercise in very severe COPD.

M Montes de Oca1, J Rassulo, B R Celli.   

Abstract

Chronic obstructive pulmonary disease (COPD) is thought to limit exercise capacity through a decreased ventilatory reserve, with cardiovascular factors playing a minimal role. We assessed respiratory muscle (RM) and cardiopulmonary function during exercise in very severe COPD (FEV1 0.79 +/- 0.17 L). We determined minute ventilation (VE), oxygen consumption (VO2), carbon dioxide production (VCO2), heart rate (HR), respiratory rate (RR), and O2 pulse with a metabolic cart. RM function was assessed from esophageal and gastric pressures. Dyspnea was assessed with a visual analog scale (VAS). Exercise capacity (peak VO2 = 36 +/- 31%), ventilatory reserve (VE/maximum voluntary ventilation [MW] = 89 +/- 31%), HR = 76 +/- 15%, and O2 pulse (O2Pmax = 45 +/- 15%) were abnormal. Peak VO2 correlated with O2Pmax(r = 0.82), the change in end-inspiratory pleural pressure (deltaPpli) (r = -0.74), maximal transdiaphragmatic pressure (Pdimax) (r = 0.68), and VEmax (r = 0.58). There were similar correlations with exercise endurance time. Multiple regression analysis revealed O2Pmax to be the best predictor of peak VO2. Thereafter, only VEmax and deltaPpli remained significant (r2 = 0.87). O2Pmax correlated with inspiratory muscle function (Pplimax, r = -0.58; Pdimax, r = 0.53; deltaPpli, r = -0.47; and PImax, r = -0.47). By multiple regression analysis, the predictors of O2Pmax were Pplimax and deltaPpli (r2 = 0.47). In very severe COPD, the impressive swings in intrathoracic pressure resulting from deranged ventilatory mechanics are the most likely cause of exercise limitation and reduced O2 pulse. The contributions of factors such as deconditioning, hypoxemia, and concurrent heart disease remain unknown.

Entities:  

Mesh:

Year:  1996        PMID: 8912737     DOI: 10.1164/ajrccm.154.5.8912737

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  26 in total

1.  Skeletal muscle weakness, reduced exercise tolerance, and COPD: is systemic inflammation the missing link?

Authors:  D D Sin; S F P Man
Journal:  Thorax       Date:  2006-01       Impact factor: 9.139

2.  Effect of salbutamol on lung function and chest wall volumes at rest and during exercise in COPD.

Authors:  A Aliverti; K Rodger; R L Dellacà; N Stevenson; A Lo Mauro; A Pedotti; P M A Calverley
Journal:  Thorax       Date:  2005-06-30       Impact factor: 9.139

3.  Impaired central hemodynamics in chronic obstructive pulmonary disease during submaximal exercise.

Authors:  Joshua R Smith; Bruce D Johnson; Thomas P Olson
Journal:  J Appl Physiol (1985)       Date:  2019-07-11

4.  The effect of pulmonary hypertension on aerobic exercise capacity in lung transplant candidates with advanced emphysema.

Authors:  Yochai Adir; Jacob E Ollech; Baruch Vainshelboim; Yael Shostak; Arie Laor; Mordechai R Kramer
Journal:  Lung       Date:  2015-03-07       Impact factor: 2.584

5.  Influence of respiratory pressure support on hemodynamics and exercise tolerance in patients with COPD.

Authors:  Cristino Carneiro Oliveira; Cláudia Regina Carrascosa; Audrey Borghi-Silva; Danilo C Berton; Fernando Queiroga; Eloara M V Ferreira; Luiz E Nery; J Alberto Neder; J Alberto Neder
Journal:  Eur J Appl Physiol       Date:  2010-03-06       Impact factor: 3.078

6.  Effect of heliox on heart rate kinetics and dynamic hyperinflation during high-intensity exercise in COPD.

Authors:  Pierantonio Laveneziana; Gabriele Valli; Paolo Onorati; Patrizia Paoletti; Alessandro Maria Ferrazza; Paolo Palange
Journal:  Eur J Appl Physiol       Date:  2010-09-18       Impact factor: 3.078

7.  Pulmonary hyperinflation and left ventricular mass: the Multi-Ethnic Study of Atherosclerosis COPD Study.

Authors:  Benjamin M Smith; Steven M Kawut; David A Bluemke; Robert C Basner; Antoinette S Gomes; Eric Hoffman; Ravi Kalhan; João A C Lima; Chia-Ying Liu; Erin D Michos; Martin R Prince; LeRoy Rabbani; Daniel Rabinowitz; Daichi Shimbo; Steven Shea; R Graham Barr
Journal:  Circulation       Date:  2013-03-14       Impact factor: 29.690

8.  Bronchodilator effect on ventilatory, pulmonary gas exchange, and heart rate kinetics during high-intensity exercise in COPD.

Authors:  Pierantonio Laveneziana; Paolo Palange; Josuel Ora; Dario Martolini; Denis E O'Donnell
Journal:  Eur J Appl Physiol       Date:  2009-08-27       Impact factor: 3.078

Review 9.  Strategies for cardiopulmonary exercise testing of pectus excavatum patients.

Authors:  Moh H Malek; Jared W Coburn
Journal:  Clinics (Sao Paulo)       Date:  2008-04       Impact factor: 2.365

Review 10.  Hyperinflation and its management in COPD.

Authors:  Luis Puente-Maestu; William W Stringer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.